Does Wegovy Cause Kidney Stones?

Summary: Kidney stones are not listed on the FDA Wegovy label as a direct adverse event, but vomiting and diarrhea concentrate urine, so 2.5 to 3 liters of fluid a day is the single best prevention step.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

The short answer: kidney stones are not on the FDA Wegovy label as a direct adverse reaction ^[1]. The STEP weight loss trials that supported Wegovy's approval did not flag nephrolithiasis as a safety signal. What the label does warn about is acute kidney injury secondary to volume depletion from severe nausea, vomiting, and diarrhea. That same volume depletion is the indirect path to kidney stones, which makes the concern legitimate even though the drug itself is not the culprit.

If you are on Wegovy and worried about stones, the question to answer is not "will the drug crystallize my urine." It is "am I losing more fluid than I am replacing." Get the hydration math right and the risk drops to roughly baseline. Get it wrong and you create exactly the urine chemistry that grows stones.

What the FDA label actually says

The Wegovy prescribing information lists the most common adverse reactions as nausea (44%), diarrhea (30%), vomiting (24%), constipation, abdominal pain, headache, fatigue, dyspepsia, dizziness, and gastroenteritis ^[1]. Nephrolithiasis is not on that list. Kidney stones did not show up as a notable adverse event in the STEP 1 through STEP 4 trials enrolling roughly 4,500 patients.

What the label does include, in the Warnings and Precautions section, is acute kidney injury. The exact wording: postmarketing reports describe AKI and worsening of chronic renal failure, sometimes requiring hemodialysis, in patients treated with GLP-1 receptor agonists. Most reports occurred in patients who had nausea, vomiting, or diarrhea leading to volume depletion. That same volume depletion is the soil that grows stones.

So the FDA position, translated: Wegovy does not cause stones, but it can cause the dehydration that causes stones. The downstream risk is real, the upstream mechanism is preventable.

Stone biology in two paragraphs

A kidney stone is a crystal that grew large enough to cause symptoms. The crystal forms when urine concentrations of stone-forming compounds, mostly calcium, oxalate, uric acid, and phosphate, exceed their solubility limit. The most common stone composition in the United States is calcium oxalate, around 75% of cases. Uric acid stones run about 10%. The rest are struvite (infection stones), calcium phosphate, and cystine.

Three variables push urine toward stone formation. First, low urine volume, which raises the concentration of every solute at once. Second, high excretion of a stone-forming compound, like more oxalate hitting the urine from diet or absorption changes. Third, low urinary citrate, because citrate normally binds calcium in solution and keeps it from precipitating. The American Urological Association guideline on stone prevention puts urine volume at the top of the list of modifiable factors, and recommends a fluid intake sufficient to produce at least 2.5 liters of urine per day ^[2]. That is the single largest lever a patient can pull.

Why dehydration is the load-bearing risk

Wegovy slows gastric emptying and suppresses appetite. It also blunts thirst, which sounds minor and is not. People on Wegovy routinely report that they "forget to drink" in the same way they forget to eat. Layer on the GI side effects that hit hardest during dose escalation, nausea at week one, vomiting if titration is aggressive, diarrhea in roughly 30% of users, and the fluid balance turns negative without the patient noticing.

Negative fluid balance produces concentrated urine. Concentrated urine grows crystals. The National Kidney Foundation summarizes the chain plainly: dehydration is one of the most common causes of kidney stones, and the easiest way to prevent both is to keep urine pale yellow ^[4]. That color check is the cheapest diagnostic in medicine. If your urine looks like apple juice for three days running, you are underwater on fluid intake regardless of how many cups you think you drank.

The second mechanism worth understanding is what rapid weight loss does to urine chemistry. When the body breaks down fat fast, it raises uric acid production. Uric acid spills into the urine, lowers pH, and creates conditions favorable to uric acid stones. Bariatric surgery studies show this clearly: kidney stone risk roughly doubles in the first two years after Roux-en-Y gastric bypass, driven by hyperoxaluria, low urine volume, and low urinary citrate ^[5]. Wegovy produces slower weight loss than bypass, so the analogy is imperfect, but the metabolic direction is the same. Fast loss, altered urine chemistry, more stones.

Prevention: the numbers worth memorizing

Hydration target: 2.5 to 3 liters per day. The AUA guideline target is at least 2.5 liters of urine output, which usually means 3 liters of total fluid intake for an average adult ^[2]. Water counts. Decaf tea counts. Coffee counts (slightly diuretic, net positive). Sparkling water counts. Sugary sodas do not count because they raise stone risk on their own.

Citrate intake. Citrate is the natural inhibitor of calcium stone formation. Drinking citrus fluids that are real fruit juice gives you citrate. Half a lemon squeezed into a liter of water, sipped through the day, raises urinary citrate measurably. So does an orange a day. Crystal Light "lemonade" does not have meaningful citrate; only actual lemon or lime juice does. Potassium citrate as a prescription tablet is the urologist's choice for recurrent stone formers, but a dietary lemon-water habit is a reasonable starter move.

Oxalate moderation, not elimination. The internet tells stone-formers to fear spinach. The nephrology literature is more nuanced. If you have a history of calcium oxalate stones and you are eating large daily portions of high-oxalate foods (spinach, rhubarb, almonds, cashews, beet greens, chocolate) while not getting enough dietary calcium, you stack the risk. The fix is not to eliminate those foods. It is to pair them with calcium-containing food at the same meal. Calcium in the gut binds oxalate and carries it out in stool, so a yogurt with your spinach salad lowers oxalate absorption. Counterintuitively, low-calcium diets raise stone risk, not lower it.

Sodium under 2,300 mg per day. Every gram of extra sodium dragged across the kidney pulls calcium into the urine with it. High-sodium diets raise urinary calcium independent of how much calcium you eat. Most American adults consume 3,400 mg or more daily. On Wegovy, with appetite suppressed and meals smaller, the natural pattern is to lean on convenience foods that are sodium-heavy. Watch the labels.

Dietary calcium from food, 1,000 to 1,200 mg per day. Get it from yogurt, milk, cheese, leafy greens, sardines. Avoid taking calcium supplements between meals, which can raise stone risk because the calcium has no food oxalate to bind to.

During titration, watch the GI symptoms

The first eight weeks on Wegovy are when nausea and vomiting are most likely. The dose climbs 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg over 16 weeks. If you are vomiting more than once or twice in any week, you are losing fluid and electrolytes faster than appetite-driven drinking will replace. Two practical moves:

1. Slow the titration. The label allows extra time at any dose step if side effects are intense. Stretching a step from 4 weeks to 8 is a normal clinical accommodation, not a failure.
2. Treat the symptom. Prescription ondansetron handles nausea well. Loperamide handles diarrhea. Neither addresses the underlying dose-dependent gut signal, but they let you keep fluids down while your gut adapts.

If you cannot keep fluids down for a 24-hour stretch, do not push through. Call the prescriber, hold the next dose, get an oral rehydration solution if you can keep small sips down, and watch for the kidney-injury warning signs: very dark urine, peeing much less than usual, dizziness on standing, confusion. Those are ER signs.

What an acute stone feels like, and what to do

Renal colic does not creep up. It arrives. The textbook presentation is sharp, cramping pain in one flank that radiates around toward the groin, comes in waves, and is not relieved by changing position. People describe it as the worst pain they have ever experienced, often worse than childbirth. Other features: blood in the urine (pink, red, or smoky brown), nausea and vomiting that are pain-driven rather than gut-driven, an urgent need to urinate, sometimes a burning sensation.

The ER will run urinalysis, blood work for kidney function, and a non-contrast CT of the kidneys, ureters, and bladder (CT KUB), which is the imaging gold standard for stones. Small stones under 5 mm usually pass on their own with hydration and pain control; stones 5 to 10 mm are a coin flip; stones over 10 mm typically need a urological procedure (ureteroscopy, shock wave lithotripsy, or rarely percutaneous nephrolithotomy).

If this is your first stone, ask the urology team to send the stone for compositional analysis when it passes. The composition (calcium oxalate vs. uric acid vs. struvite vs. cystine) determines the prevention strategy going forward. Recurrent stone formers, defined as two or more stones in a lifetime, warrant a metabolic workup: 24-hour urine collection measuring volume, calcium, oxalate, citrate, uric acid, sodium, and creatinine. That panel tells the urologist exactly which lever to pull.

What the GLP-1 weight loss data say about stone-promoting metabolism

The relationship between GLP-1 weight loss and stone biology is mixed and worth being honest about. On one side, weight loss lowers some stone risk factors. Reducing visceral adiposity improves insulin sensitivity, which tends to raise urinary pH and reduce uric acid stone risk. Lower body weight reduces sodium intake passively because total food volume is down. Improved glycemic control on semaglutide reduces hyperinsulinemia, which is a driver of low urinary citrate in metabolic syndrome.

On the other side, rapid weight loss of any cause, including bariatric surgery and very-low-calorie diets, has been associated with transiently higher stone risk in the active weight loss phase, driven by lower urine volume, higher urinary uric acid, and (in malabsorptive procedures) hyperoxaluria from fat malabsorption. Wegovy is not malabsorptive, so the hyperoxaluria pathway does not strongly apply. The volume and uric acid pathways do, modestly, during active loss.

The cleanest renal data on semaglutide come from the FLOW trial, which enrolled 3,533 patients with type 2 diabetes and chronic kidney disease and randomized them to semaglutide 1.0 mg weekly or placebo ^[3]. Semaglutide reduced the composite renal endpoint (major kidney disease events plus cardiovascular death) by 24% and slowed eGFR decline. FLOW was a kidney function trial, not a kidney stone trial, but it is the strongest evidence to date that semaglutide is protective for the kidneys at a population level, not harmful. Stone formation was not a reported endpoint.

The net for most patients: GLP-1 weight loss is probably slightly stone-promoting during the active loss phase if hydration slips, and probably stone-neutral to stone-protective at steady state once weight has stabilized and urine chemistry normalizes. The first 12 months are the window where prevention matters most.

Wegovy versus other GLP-1 stone signals

Wegovy is not unusual within the GLP-1 class on this question. Ozempic (semaglutide 1.0 mg), Mounjaro and Zepbound (tirzepatide), and Saxenda (liraglutide) all carry the same indirect dehydration-to-stones logic and none list stones as a labeled adverse event. Wegovy has the largest dose at 2.4 mg weekly, which produces the most GI side effects in absolute terms, which arguably makes the dehydration risk slightly larger than for a 1 mg semaglutide patient.

When to see a urologist proactively

Most Wegovy users do not need a urology consultation. The people who do, before any symptoms appear:

• Anyone with one or more prior kidney stones. Recurrence rates approach 50% within 5 years for unselected first-time stone formers ^[2], and Wegovy's dehydration risk pushes that number up. A pre-treatment 24-hour urine collection sets a baseline.
• Anyone with a single functioning kidney. The downside risk of an obstructing stone is much higher.
• Anyone with cystinuria, primary hyperoxaluria, or distal renal tubular acidosis. These conditions independently raise stone risk and need specialty management.
• Anyone with chronic kidney disease at stage 3 or worse. Wegovy is still indicated in CKD per the FLOW data, but stone-related obstruction in a CKD kidney is a bigger functional hit.

For everyone else, prevention is a primary care conversation: confirm the hydration target, review the dietary points, and check basic metabolic panel and urinalysis at the routine intervals your prescriber already uses for Wegovy monitoring.

Common questions

Does Wegovy directly cause kidney stones?

No. The FDA Wegovy label does not list kidney stones as an adverse reaction, and the STEP trials did not flag stones as a safety signal. The risk is indirect, through dehydration from GI side effects.

How much water should I drink on Wegovy to prevent stones?

Aim for 2.5 to 3 liters of total fluid daily, enough to produce at least 2 to 2.5 liters of pale yellow urine. The American Urological Association guideline puts 2.5 liters of urine output as the prevention target for any stone-former.

Does Ozempic cause kidney problems?

Ozempic shares the GLP-1 class warning for acute kidney injury driven by volume depletion from nausea, vomiting, and diarrhea. Direct kidney damage from the drug itself is not established. The FLOW trial showed semaglutide protected kidney function in patients with type 2 diabetes and CKD.

Can semaglutide cause kidney stones?

Same answer as Wegovy. Semaglutide is the active ingredient in both Wegovy and Ozempic. No direct causal link in trials, but dehydration from side effects can raise stone risk.

Does Wegovy cause kidney failure?

Wegovy can contribute to acute kidney injury, which is a temporary functional decline, in patients who become severely volume-depleted. Permanent kidney failure is rare and almost always tied to prolonged uncorrected dehydration in someone with pre-existing kidney disease.

Does Wegovy cause UTIs?

Wegovy does not directly cause urinary tract infections, but dehydration concentrates urine and reduces flushing, which can make UTIs more likely. The same hydration target that prevents stones lowers UTI risk.

Should I avoid spinach and nuts on Wegovy if I have had stones?

Moderate them rather than avoid them. The bigger lever is dietary calcium with meals (yogurt, cheese, sardines) which binds oxalate in the gut before it reaches the kidney. Pair high-oxalate foods with calcium-containing foods at the same meal.

What if I get a kidney stone while on Wegovy, do I stop the drug?

Not necessarily. A single small stone that passes with hydration usually does not require stopping. Recurrent or large obstructing stones warrant a urology workup and a discussion with your prescriber about whether continuing Wegovy is appropriate. The benefits of weight loss and kidney function preservation often outweigh the marginal stone risk if hydration is corrected.

Does Wegovy help kidney disease?

For patients with type 2 diabetes and chronic kidney disease, semaglutide at 1.0 mg weekly (Ozempic dose) reduced major kidney disease events and slowed kidney function decline in the FLOW trial. Wegovy at 2.4 mg has not been formally tested in CKD endpoints, but the mechanism is the same molecule.

When do kidney stone symptoms appear after starting Wegovy?

There is no defined window because the drug does not form stones directly. If you become significantly dehydrated during titration, urine concentration can favor crystal growth over weeks to months. Most reported stone events cluster around the periods of heaviest GI side effects.

What this page does not cover

This article is the kidney stone question specifically. Related pages on this site cover broader Wegovy kidney effects, the FLOW trial in depth, gallstone risk on GLP-1s (a separate and better-documented concern), and the full Wegovy side effect profile. Use the search to find them. The hydration target on this page is the same target that prevents most of the other dehydration-related complications, so if you take only one number with you, take 2.5 to 3 liters per day.